全文获取类型
收费全文 | 1789篇 |
免费 | 189篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 157篇 |
妇产科学 | 25篇 |
基础医学 | 226篇 |
口腔科学 | 98篇 |
临床医学 | 174篇 |
内科学 | 337篇 |
皮肤病学 | 52篇 |
神经病学 | 63篇 |
特种医学 | 178篇 |
外科学 | 329篇 |
综合类 | 39篇 |
预防医学 | 109篇 |
眼科学 | 43篇 |
药学 | 60篇 |
中国医学 | 2篇 |
肿瘤学 | 106篇 |
出版年
2023年 | 17篇 |
2022年 | 13篇 |
2021年 | 17篇 |
2020年 | 17篇 |
2019年 | 10篇 |
2018年 | 51篇 |
2017年 | 53篇 |
2016年 | 51篇 |
2015年 | 68篇 |
2014年 | 82篇 |
2013年 | 110篇 |
2012年 | 58篇 |
2011年 | 47篇 |
2010年 | 85篇 |
2009年 | 94篇 |
2008年 | 43篇 |
2007年 | 59篇 |
2006年 | 52篇 |
2005年 | 42篇 |
2004年 | 37篇 |
2003年 | 35篇 |
2002年 | 34篇 |
2001年 | 26篇 |
2000年 | 25篇 |
1999年 | 29篇 |
1998年 | 108篇 |
1997年 | 89篇 |
1996年 | 107篇 |
1995年 | 69篇 |
1994年 | 79篇 |
1993年 | 42篇 |
1992年 | 19篇 |
1991年 | 30篇 |
1990年 | 16篇 |
1989年 | 32篇 |
1988年 | 31篇 |
1987年 | 32篇 |
1986年 | 30篇 |
1985年 | 27篇 |
1984年 | 16篇 |
1983年 | 13篇 |
1982年 | 21篇 |
1981年 | 15篇 |
1980年 | 17篇 |
1979年 | 6篇 |
1978年 | 6篇 |
1977年 | 9篇 |
1976年 | 13篇 |
1975年 | 9篇 |
1969年 | 4篇 |
排序方式: 共有2006条查询结果,搜索用时 15 毫秒
51.
Irene Paganini Vivian Y Chang Gabriele L Capone Jeremie Vitte Matteo Benelli Lorenzo Barbetti Roberta Sestini Eva Trevisson Theo JM Hulsebos Marco Giovannini Stanley F Nelson Laura Papi 《European journal of human genetics : EJHG》2015,23(7):963-968
Schwannomatosis is characterized by the development of multiple non-vestibular, non-intradermal schwannomas. Constitutional inactivating variants in two genes, SMARCB1 and, very recently, LZTR1, have been reported. We performed exome sequencing of 13 schwannomatosis patients from 11 families without SMARCB1 deleterious variants. We identified four individuals with heterozygous loss-of-function variants in LZTR1. Sequencing of the germline of 60 additional patients identified 18 additional heterozygous variants in LZTR1. We identified LZTR1 variants in 43% and 30% of familial (three of the seven families) and sporadic patients, respectively. In addition, we tested LZTR1 protein immunostaining in 22 tumors from nine unrelated patients with and without LZTR1 deleterious variants. Tumors from individuals with LZTR1 variants lost the protein expression in at least a subset of tumor cells, consistent with a tumor suppressor mechanism. In conclusion, our study demonstrates that molecular analysis of LZTR1 may contribute to the molecular characterization of schwannomatosis patients, in addition to NF2 mutational analysis and the detection of chromosome 22 losses in tumor tissue. It will be especially useful in differentiating schwannomatosis from mosaic Neurofibromatosis type 2 (NF2). However, the role of LZTR1 in the pathogenesis of schwannomatosis needs further elucidation. 相似文献
52.
Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure 总被引:4,自引:0,他引:4
BACKGROUND: Renal cell therapy in conjunction with continuous hemofiltration techniques may provide important cellular metabolic activities to patients with acute renal failure (ARF) and may thereby change the natural history of this disorder. The development of a tissue-engineered bioartificial kidney consisting of a conventional hemofiltration cartridge in series with a renal tubule assist device (RAD) containing 10(9) human renal proximal tubule cells provides an opportunity to evaluate this form of therapy in patients with ARF in the intensive care unit. METHODS: Nine patients with ARF and multi-organ systems failure (MOSF) have been treated so far with a tissue-engineered kidney in an FDA-approved Phase I/II clinical study currently underway. Acute physiologic parameters and serum cytokine levels were assessed before, during and after treatment with a bioartificial kidney. RESULTS: Use of the RAD in this clinical setting demonstrates maintenance of cell viability and functionality. Cardiovascular stability appears to be maintained during RAD treatment. Human tubule cells in the RAD demonstrated differentiated metabolic and endocrinologic activity. Acute physiologic and plasma cytokine data demonstrate that renal cell therapy is associated with rapid and variable responses in patients with ARF and MOSF. CONCLUSION: The initial clinical experience with the bioartificial kidney and the RAD suggests that renal tubule cell therapy may provide a dynamic and individualized treatment program as assessed by acute physiologic and biochemical indices. 相似文献
53.
Takahama Jr Ademar de Sousa Vitoria Iaros Tanaka Elisa Emi Ono Evelise Ito Fernanda Akemi Nakanishi Costa Priscila Paganini Pedriali Maria Beatriz Bergonse Pereira de Lima Heliton Gustavo Fornazieri Marco Aurélio Correia Leticia Sassaki Cardoso Lucienne Tibery Queiroz de Maio Carrilho Claudia Maria Dantas 《Clinical oral investigations》2021,25(3):1217-1222
Clinical Oral Investigations - This a cross-sectional study to evaluate the association between oral health findings and ventilator-associated pneumonia (VAP) among critically ill patients in... 相似文献
54.
55.
Development of large numbers of mast cells at sites of idiopathic chronic dermatitis in genetically mast cell-deficient WBB6F1-W/Wv mice 总被引:15,自引:1,他引:15
The normal skin and other tissues of adult mast cell-deficient WBB6F1- W/Wv or WCB6F1-Sl/Sld mice contain less than 1.0% the number of mast cells present in the corresponding tissues of the congenic normal (+/+) mice. As a result, genetically mast cell-deficient WBB6F1-W/Wv or WCB6F1-Sl/Sld mice are widely used for studies of mast cell differentiation and function. We found that mast cells developed at sites of idiopathic chronic dermatitis in WBB6F1-W/Wv mice and that the number of mast cells present in the skin of WBB6F1-W/Wv mice was proportional to the severity of the dermatitis (in ear skin, there were 33 +/- 4 mast cells/mm2 of dermis at sites of severe dermatitis v 9 +/- 3 at sites of mild dermatitis, 0.8 +/- 0.3 in skin without dermatitis, and 100 +/- 7 in the normal skin of congenic WBB6F1-+/+ mice; in back skin, the corresponding values were 2.0 +/- 0.6, 1.1 +/- 0.9, 0.025 +/- 0.025, and 26.2 +/- 3.2). The development of mast cells was a local, not systemic, consequence of the dermatitis. Thus, WBB6F1-W/Wv mice with severe dermatitis lacked mast cells in skin not showing signs of dermatitis and also in the peritoneal cavity, stomach, cecum, and tongue. Idiopathic chronic dermatitis was not associated with the local development of mast cells in WCB6F1-Sl/Sld mice, a mutant whose mast cell deficiency is due to a mechanism distinct from that of WBB6F1-W/Wv mice. These findings may have implications for understanding the nature of the mast cell deficiency in WBB6F1-W/Wv and WCB6F1-Sl/Sld mice and for the use of these mutants to analyze mast cell differentiation and function. 相似文献
56.
Luca Micci Emily S. Ryan Rémi Fromentin Steven E. Bosinger Justin L. Harper Tianyu He Sara Paganini Kirk A. Easley Ann Chahroudi Clarisse Benne Sanjeev Gumber Colleen S. McGary Kenneth A. Rogers Claire Deleage Carissa Lucero Siddappa N. Byrareddy Cristian Apetrei Jacob D. Estes Jeffrey D. Lifson Michael Piatak Jr. Nicolas Chomont Francois Villinger Guido Silvestri Jason M. Brenchley Mirko Paiardini 《The Journal of clinical investigation》2015,125(12):4497-4513
Despite successful control of viremia, many HIV-infected individuals given antiretroviral therapy (ART) exhibit residual inflammation, which is associated with non–AIDS-related morbidity and mortality and may contribute to virus persistence during ART. Here, we investigated the effects of IL-21 administration on both inflammation and virus persistence in ART-treated, SIV-infected rhesus macaques (RMs). Compared with SIV-infected animals only given ART, SIV-infected RMs given both ART and IL-21 showed improved restoration of intestinal Th17 and Th22 cells and a more effective reduction of immune activation in blood and intestinal mucosa, with the latter maintained through 8 months after ART interruption. Additionally, IL-21, in combination with ART, was associated with reduced levels of SIV RNA in plasma and decreased CD4+ T cell levels harboring replication-competent virus during ART. At the latest experimental time points, which were up to 8 months after ART interruption, plasma viremia and cell-associated SIV DNA levels remained substantially lower than those before ART initiation in IL-21–treated animals but not in controls. Together, these data suggest that IL-21 supplementation of ART reduces residual inflammation and virus persistence in a relevant model of lentiviral disease and warrants further investigation as a potential intervention for HIV infection. 相似文献
57.
58.
59.
60.